Mark D. Novara - 15 Dec 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & CHIEF COMMERCIAL OFFICER
Signature
/s/ Rachel Malina, Attorney-in-Fact for Mark D. Novara
Issuer symbol
TNDM
Transactions as of
15 Dec 2023
Net transactions value
$0
Form type
4
Filing time
19 Dec 2023, 16:18:02 UTC
Previous filing
17 Nov 2023
Next filing
28 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +88,975 $0.000000 88,975 15 Dec 2023 Common Stock 88,975 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F2 Restricted stock units (RSU) vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.